Head of Phase I Unit at Rigshospitalet: A matter of time before we stop recruiting for clinical trials
The first time pharmaceutical companies test a new drug on humans, it is a requirement that an intensive care team is at the ready at the hospital where the study is being conducted. As more corona patients are admitted, capacity is being squeezed, and it is only a matter of time before Rigshospitalet's special Phase I Unit has to stop recruiting new patients.
It is likely only a matter of days or weeks before Rigshospitalet's special Phase I Unit will have to cease recruitment of new patients for early clinical trials on humans, which the unit conducts together with the pharmaceutical industry.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
